Article information
Full text is only aviable in PDF
Bibliografía
[1.]
K.F. Chung.
Platelet-activating factor in inflammation and pulmonary disorders.
Clin Sci, 83 (1992), pp. 127-138
[2.]
B.W. Christman, P.L. Lefferts, G.A. King, J.R. Snapper.
Role of circulating platelets in PAF-induced pulmonary dysfunction in awake sheep.
J Appl Physiol, 64 (1988), pp. 2.033-2.041
[3.]
F.M. Cuss, C.M.S. Dixon, P.J. Bames.
Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness.
Lancet, 2 (1986), pp. 189-192
[4.]
M. Saetta, A. Di Stefano, C. Rosina, G. Thiene, L.M. Fabbri.
Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma.
Am Rev Respir Dis, 143 (1991), pp. 138-143
[5.]
R. Rodríguez-Roisin, J. Roca.
Contributions of multiple inert gas elimination technique to pulmonary medicine. 3: Bronchial asthma.
Thorax, 49 (1994), pp. 1.027-1.033
[6.]
P.D. Wagner, G. Hedenstierna, R. Rodríguez-Roisin.
Gas exchange, expiratory flow obstruction and the clinical spectrum of asthma.
Eur Respir J, 9 (1996), pp. 1.278-1.282
[7.]
D.M. McDonald.
Neurogenic inflammation in the respiratory tract: actions of the sensory nerve mediators on blood vessels and epithelium of the airway mucosa.
Am Rev Respir Dis, 136 (1987), pp. S65-S67
[8.]
D.M. McDonald.
The ultrastructure and permeability of tracheobronchial blood vessels in health and disease.
Eur Respir J, 3 (1990), pp. S572-S585
[9.]
R. Rodríguez-Roisin, M.A. Félez, K.F. Chung, J.A. Barbera, P.D. Wagner, A. Cobos, et al.
Platelet activating factor causes ventilationperfusion mismatch in humans.
J Clin Invest, 93 (1994), pp. 188-194
[10.]
M.A. Félez, J. Roca, J.A. Barbera, C. Santos, M. Rotger, K.F. Chung, et al.
Inhaled platelet activating factor worsens gas exchange in mild asthma.
Am J Respir Crit Care Med, 150 (1994), pp. 369-373
[11.]
A.E. Rubin, L.J. Smith, R. Patterson.
The bronchoconstrictor properties of platelet-activating factor in humans.
Am Rev Respir Dis, 136 (1987), pp. 1.145-1.151
[12.]
P.D. Wagner, G.E. Gale, R.E. Moon, J. Torre-Bueno, B.W. Stolp, H.A. Saltzman.
Pulmonary gas exchange in human exercising at sea level and simulated altitude.
J Appl Physiol, 61 (1986), pp. 260-270
[13.]
C. Mélot, R. Naeije, R. Hallemans, P.H. Lejeune, P. Mols.
Hypoxic pulmonary vasoconstriction and pulmonary gas exchange in normal man.
Respir Physiol, 68 (1987), pp. 11-27
[14.]
A. Ferrer, J. Roca, P.D. Wagner, F.A. López, R. Rodríguez-Roisin.
Airways obstruction and ventilation-perfusion relationships in acute severe asthma.
Am Rev Respir Dis, 147 (1993), pp. 579-584
[15.]
P.R.A. Johnson, J.L. Black, C.L. Armour.
Platelet-activating factor-induced contraction of human isolated bronchus.
Eur Respir J, 5 (1992), pp. 970-974
[16.]
R.R. Schellenberg.
Airway responses to platelet-activating factor.
Am Rev Respir Dis, 136 (1987), pp. S28-S32
[17.]
D. Yager, J. Butler, J. Bastacky, E. Israel, G. Smith, J.M. Drazen.
Amplification of airway constriction due to liquid filling of airway interstices.
J Appl Physiol, 66 (1989), pp. 2.873-2.884
[18.]
K. Tokuyama, J.O. Lotvall, P.J. Bames, K.F. Chung.
Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of microvascular leakage..
Am Rev Respir Dis, 143 (1991), pp. 1.345-1.349
[19.]
R. Rodríguez-Roisin, A. Ferrer, D. Navajas, A.G.N. Agustí, P.D. Wagner, J. Roca.
Ventilation-perfusion mismatch after methacholine challenge in patients with mild bronchial asthma.
Am Rev Respir Dis, 144 (1991), pp. 88-94
[20.]
R.E. Louis, M.F. Radermecker.
Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: comparison with methacholine.
Eur Respir J, 9 (1996), pp. 1.414-1.420
[21.]
J. Roca, M.A. Félez, K.F. Chung, J.A. Barbera, M. Rotger, C. Santos, et al.
Salbutamol inhibits pulmonary effects of platelet activating factor in man.
Am J Respir Care Med, 151 (1995), pp. 1.740-1.745
[22.]
J.R. Masclans, J.A. Barbera, W. MacNee, J. Pavia, C. Piera, F. Lomefta, et al.
Salbutamol reduces pulmonary neutrophil sequestration after platelet activating factor in normal subjects.
Am J Respir Crit Care Med, 154 (1996), pp. 529-532
[23.]
Díaz O, Barbera JA, Marrades R, Chung KF, Roca F, Rodríguez-Rovira R. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonist in mild asthma is not due to bronchodilation. Am J Respir Crit Care Med (en prensa). in press.
[24.]
F.W.K. Tam, J. Clague, C.M. Dixon, A.W.J. Stuttle, B.L. Henderson, A.M. Peters, et al.
Inhaled platelet-activating factor causes pulmonary neutrophil sequestration in normal humans.
Am Rev Respir Dis, 146 (1992), pp. 1.003-1.008
[25.]
M. Kurosawa, T. Yamashita, F. Kurimoto.
Increased levels of blood platelet activating factor in bronchial asthmatic patients with active symptoms.
Allergy, 49 (1994), pp. 60-63
[26.]
L. Kuitert, N.C. Bames.
PAF and asthma time for appraisal?.
Clin Exp Allergy, 25 (1995), pp. 1.159-1.162
[27.]
J.A. Nadel.
Genetics reveals importance of platelet activating factor in asthma and possibly other inflammatory States.
J Clin Invest, 97 (1996), pp. 2.689-2.690
